
Glimijoy MV 1mg/500mg/0.2mg Tablet
Marketer
Vjovis Health Care Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimijoy MV 1mg/500mg/0.2mg Tablet
Diabetic patients using the anti-diabetic combination medication, Glimijoy MV 1mg/500mg/0.2mg tablets, should adhere to their prescribed dosage. This medication manages blood glucose in adults with type 2 diabetes. Administer this medicine with food at the same time daily for optimal efficacy. Dosage adjustments may occur based on individual blood sugar responses and should be guided by your physician. Continuous use is crucial; discontinuation without medical supervision may lead to dangerously elevated blood sugar, potentially resulting in kidney complications, vision impairment, nerve damage, and limb loss. Remember, Glimijoy MV is one component of a comprehensive diabetes management plan, including dietary changes, exercise, and weight control as recommended by your healthcare professional. Maintaining a healthy lifestyle is paramount. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headaches, and tremors. Carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counter this. Alcohol consumption raises hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of heart disease should consult their doctor before commencing treatment. Pregnant or lactating women require physician consultation. Regular blood glucose monitoring, along with blood cell and liver function tests, may be necessary as directed by your physician.
Uses of Glimijoy MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glimijoy MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimijoy MV 1mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Glimijoy MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimijoy MV 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimijoy MV 1mg/500mg/0.2mg tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
How Glimijoy MV 1mg/500mg/0.2mg Tablet works:
Each Glimijoy MV tablet (1mg/500mg/0.2mg) contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimijoy MV 1mg/500mg/0.2mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Glimijoy MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Glimijoy MV 1mg/500mg/0.2mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
For individuals with kidney impairment, Glimijoy MV 1mg/500mg/0.2mg Tablet carries a high risk and should be omitted. Patients with severe kidney disease should definitely not use this medication. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Glimijoy MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe liver dysfunction.
What if you forget to take Glimijoy MV 1mg/500mg/0.2mg Tablet :
Should you forget a dose of Glimijoy MV 1mg/500mg/0.2mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimijoy MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
